Yoshida, E M <br/><br/>
Re-treatment with peginterferon alfa-2a and ribavirin in patients with chronic hepatitis C who have relapsed or not responded to a first course of pegylated interferon-based therapy.  [electronic resource] 

 -  Canadian journal of gastroenterology = Journal canadien de gastroenterologie  Mar 2009 
 - 180-4 p.  digital 
<br/><br/> Publication Type: Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0835-7900 
<br/><br/><label>Standard No.: </label>10.1155/2009/470532  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Antiviral Agents--administration & dosage<br/>Dose-Response Relationship, Drug<br/>Drug Therapy, Combination<br/>Female<br/>Genotype<br/>Hepatitis C, Chronic--drug therapy<br/>Humans<br/>Interferon alpha-2<br/>Interferon-alpha--administration & dosage<br/>Liver Cirrhosis--physiopathology<br/>Male<br/>Middle Aged<br/>Polyethylene Glycols--administration & dosage<br/>Recombinant Proteins<br/>Recurrence<br/>Retreatment<br/>Retrospective Studies<br/>Ribavirin--administration & dosage<br/>Treatment Outcome<br/>Young Adult